Moorestown, New Jersey, United States
seeking biotech alpha is biotecMAX 生物技术最大 1/24/2021 the heart of biotech
thank you for visiting seeking biotech alpha
感谢您访问寻求生物技术 寻求 α
grazie per la visita alla ricerca di biotech alpha
biotecMAX™
Revival’s In The Air–BiotecWARS™ Jan. 20, 2021 7:10 PM ET|
Revival’s In The Air–BiotecWARS™
Jan. 20, 2021 7:10 PM ET| About: AbbVie Inc. (ABBV), AZN, BGNE, BMRN, BMY, BNTX, JNJ, LLY, MRK, MRNA, PFE, RHHBY, SGEN
Summary
After a storm sometimes skies become clearer.
Many companies are now considering or have already concluded that they will no longer fund politicos, either all of them, or some of them.
“The World’s Most Loathed Industry Gave Us a Vaccine in Record Time”.
I have been adding long positions in (MRK) (GILD) (AMGN) (JNJ) (ABBV) (AZN) since September 2020 to the "SeekingBiotechAlpha" portfolio.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5545353-revival-s-in-air-biotecwars
2019
2020
2021
2021 & 2020
COVID-19 Vaccinations in the United States
Maps, charts, and data provided by the CDC, updated daily by 8 pm ET
biotecMAX™
Covid-19 Vaccine Tracker
More Than 63 Million Shots
Given: Covid-19 Tracker
The U.S. has administered 21.1 million doses; vaccination campaign goes global Updated: January 23, 2021, 5:54 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 60.3 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 19.8 million doses; Europe’s rollout begins Updated: January 22, 2021, 5:55 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 56.7 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 18.4 million doses; Europe’s rollout begins Updated: January 21, 2021, 6:42 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 54.3 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 17.2 million doses; Europe’s rollout begins Updated: January 20, 2021, 6:34 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 51.9 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 16.3 million doses; Europe’s rollout begins Updated: January 20, 2021, 9:16 AM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 46.2 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 15.6 million doses; Europe’s rollout begins Updated: January 19, 2021, 6:05 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 44 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 14.7 million doses; Europe’s rollout begins Updated: January 18, 2021, 5:13 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 42.2 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 14.3 million doses; Europe’s rollout begins Updated: January 17, 2021, 5:31 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 39.7 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 13.7 million doses; Europe’s rollout begins Updated: January 16, 2021, 7:08 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 37.9 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 13 million doses; Europe’s rollout begins Updated: January 16, 2021, 1:47 AM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 35 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 11.9 million doses; Europe’s rollout begins Updated: January 14, 2021, 10:13 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 34.5 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 11.3 million doses; Europe’s rollout begins Updated: January 14, 2021, 7:29 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 32.4 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 10.8 million doses; Europe’s rollout beginsUpdated: January 13, 2021, 5:41 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 30.5 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 9.94 million doses; Europe’s rollout begins Updated: January 12, 2021, 5:29 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 29 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 9.27 million doses; Europe’s rollout begins Updated: January 11, 2021, 6:49 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 26 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 8.07 million doses; Europe’s rollout begins Updated: January 11, 2021, 11:13 AM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 25 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 8.02 million doses; Europe’s rollout begins Updated: January 10, 2021, 5:07 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 24 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 7.73 million doses; Europe’s rollout begins Updated: January 9, 2021, 8:30 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 18.9 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 7.05 million doses; Europe’s rollout begins Updated: January 8, 2021, 5:23 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 17.5 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 6.25 million doses; Europe’s rollout begins Updated: January 7, 2021, 6:56 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 15.9 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 5.48 million doses; Europe’s rollout begins Updated: January 6, 2021, 8:27 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 15 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 5.05 million doses; Europe’s rollout begins Updated: January 5, 2021, 6:31 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 13 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 4.66 million doses; Europe’s rollout begins Updated: January 4, 2021, 4:32 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 12.3 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 4.33 million doses; Europe’s rollout begins Updated: January 3, 2021, 8:04 PM EST
More Than 12 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 4.28 million doses; Europe’s rollout begins Updated: January 2, 2021, 4:59 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 10.8 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 3.49 million doses; Europe’s rollout begins Updated: January 1, 2021, 5:21 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 10.3 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 3.17 million doses; Europe’s rollout begins Updated: December 31, 2020, 5:29 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 6 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 3.05 million doses—the most of any country so far Updated: December 30, 2020, 11:16 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 4.2 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 1.94 million doses, according to the CDC Updated: December 26, 2020, 3:52 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
More Than 3.3 Million Shots
Given: Covid-19 Vaccine Tracker
The U.S. has administered 1.23 million doses, according to Bloomberg’s count Updated: December 24, 2020, 1:42 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
By Washington Post staff
COVID-19 Vaccinations in the United States
By Marisa Iati
QuickTake
What You Need to Know About Allergic Reactions to Covid Vaccines
By John Lauerman December 31, 2020, 12:01 AM EST
What there is to know about the Covid-19 vaccines roll out in Hong Kong
•Jan 4, 2021
South China Morning Post South China Morning Post
https://www.nytimes.com/live/2021/01/07/world/covid-19-coronavirus
L.A. County first responders told not to bring patients to hospital if survival chances are low
By Antonia Noori Farzan, Erin Cunningham, Marisa Iati, Miriam Berger, Brittany Shammas and Taylor Telford Jan. 5, 2021 at 1:55 p.m. EST
https://www.washingtonpost.com/nation/2021/01/05/coronavirus-covid-live-updates-us/
Prognosis
One Person in 50 in England Now Has Covid, Government Says
N.Y. Seeking More Vaccine Supply Ahead of Distribution Increase
Covid Spike in U.S. South Dwarfs All Earlier Regional Hot Spots
More Than 13 Million Shots Given: Covid-19 Vaccine Tracker
New UK variant is 50% more transmissible than original strain of COVID-19
•Jan 5, 2021
ABC News
Global Vaccination Efforts Roll Out Slower Than Promised
Countries are falling short of the inoculation targets set by leaders. There are more than twice as many Covid-19 patients in California hospitals now as there were a month ago.
Merkel announces an extension of the lockdown in Germany.
https://www.nytimes.com/live/2021/01/05/world/covid-19-coronavirus
LIVE UPDATES
UPDATED TUE, JAN 5 20211:19 PM EST
Covid live updates: U.S. likely to see more virus strains, Biden advisor says; FDA responds to UK vaccine delays
CNBC.com staff
https://www.cnbc.com/2021/01/05/covid-live-updates.html
miracle on ice milagro sobre hielo 冰上的奇迹
The World’s Most Loathed Industry Gave Us a Vaccine in Record Time
At least one thing went right in 2020: Pharmaceutical companies came through. Thank you, science.
By Drew Armstrong
Coronavirus: BMJ urges NYT to correct vaccine 'mixing' article
The editor of the British Medical Journal has asked the New York Times to correct an article that says UK guidelines allow two Covid-19 vaccines to be mixed.
Prognosis
PFIZER AND BIONTECH TO SUPPLY THE EUROPEAN UNION WITH 100 MILLION ADDITIONAL DOSES OF COMIRNATY®
Tuesday, December 29, 2020 - 01:11pm
- European Union orders 100 million additional doses of COMIRNATY® bringing total doses to 300 million for 27 EU member states
- All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005380/en/
PFIZER AND BIONTECH RECEIVE AUTHORIZATION IN THE EUROPEAN UNION FOR COVID-19 VACCINE
Monday, December 21, 2020 - 02:09pm
- COMIRNATY® (also known as BNT162b2) receives conditional marketing authorization from the European Commission; this milestone represents a global joint effort to advance the first authorized mRNA vaccine
- Pfizer and BioNTech are ready to immediately ship initial doses to the 27 EU member states
- Pfizer and BioNTech previously announced an agreement with the European Commission to supply 200 million vaccine doses to EU member states; the EU also has an option to purchase an additional 100 million doses in 2021
- The vaccine has now been granted a conditional marketing authorization, emergency use authorization, or temporary authorization in more than 40 countries worldwide, including all 27 EU member states
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY® (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older. This follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) positive opinion to authorize the vaccine earlier today. The EC granted this CMA in the interest of public health to help address the COVID-19 pandemic. The CMA is valid in all 27 member states of the European Union (EU).
PFIZER AND BIONTECH TO SUPPLY THE U.S. WITH 100 MILLION ADDITIONAL DOSES OF COVID-19 VACCINE
Wednesday, December 23, 2020 - 07:00am
- U.S. government orders 100 million additional doses of the Pfizer-BioNTech COVID-19 Vaccine bringing total doses for U.S. to 200 million
- All 200 million doses expected to be delivered by July 31, 2021, allowing for 100 million people in the U.S. to be vaccinated
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 Vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the original agreement announced in July 2020, the U.S. government will pay $1.95 billion for the additional 100 million doses.
UK rolls out Oxford-AstraZeneca vaccine as it battles against Covid surge
PUBLISHED MON, JAN 4 20213:01 AM ESTUPDATED MON, JAN 4 20217:22 AM ESTHolly Ellyatt@HOLLYELLYAT
UK to roll out Oxford/AstraZeneca vaccine in January: reports
Regulator could approve the jab by midweek, according to local media.
BY LAURENS CERULUS December 27, 2020 11:11 am
Oxford-AstraZeneca Covid vaccine approved by UK regulator
PUBLISHED WED, DEC 30 20201:57 AM ESTUPDATED WED, DEC 30 20207:34 AM ESTMatt Clinch@MATTCLINCH81Holly Ellyatt@HOLLYELLYATTKEY POINTS
- The Oxford-AstraZeneca vaccine is cheaper than others and does not need to be kept at the ultra-low temperatures required by the Pfizer and Moderna vaccines.
- The shot is expected to be rolled out next week.
- A vaccine by Pfizer-BioNTech has been given to 600,000 people in the U.K., according to government statistics.
AstraZeneca and Government of Canada announce agreement to supply up to 20 million doses of the AZD1222 COVID-19 vaccine
PUBLISHED25 September 2020
JANUARY 1, 20215:38 PM
AstraZeneca expects to supply two million doses of COVID-19 vaccine every week in UK -The Times
By Reuters Staff
South Africa to import 1.5M doses of the AstraZeneca vaccine
Today, 7:02 AM
Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of Patients with Severe and Critical COVID-19
December 23, 2020 6:45 am EST KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK),
Coronavirus: India approves AstraZeneca vaccine; Singapore bans visitors from South Africa
The shots could start to be transported from cold storage to Indian states as early as Saturday
All long-term pass holders and short-term visitors with travel history to South Africa within the last 14 days will not be allowed entry into Singapore
Agencies Published: 1:15pm, 1 Jan, 2021
U.S. CDC Advisory Committee on Immunization Practices Recommends Vaccination with Moderna’s COVID-19 Vaccine for Persons 18 Years and Older
December 19, 2020 at 9:44 PM ESTPDF Version
Recommendation follows yesterday’s U.S. FDA authorization for emergency use of the Moderna COVID-19 Vaccine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 19, 2020-- Moderna, Inc., (Nasdaq: MRNA
Statement on Variants of the SARS-CoV-2 Virus
December 23, 2020 at 4:10 PM ESTPDF Version
The Moderna COVID-19 Vaccine expresses the full-length Spike protein of the SARS-COV-2 virus, allowing for the generation of neutralizing antibody responses to multiple domains of the protein. The full-length Spike protein is 1,273 amino acids long, so while recent variants involve multiple mutations, for instance up to 8 amino acid changes in the spike protein of the B1.1.7 strain, these represent less than a 1% difference from the spike protein encoded by Moderna’s vaccine.
Health Canada Authorizes Moderna COVID-19 Vaccine in Canada
December 23, 2020 at 11:20 AM EST PDF Version
Authorization under Health Canada's Interim Order
Canadian government has secured 40 million doses
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 23, 2020-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order.
Lilly to begin pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19 in New Mexico
December 18, 2020
Lilly to begin pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19 in New Mexico
December 18, 2020 Tags | Product
Study will provide real-world data and insight on various infusion setting experiences Plan to study bamlanivimab in a diverse group of participants, including Native American communities INDIANAPOLIS , Dec. 18, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to begin
Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine
December 11, 2020
Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine
December 11, 2020 Tags | Product
INDIANAPOLIS , Dec. 11, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that The New England Journal of Medicine has published peer-reviewed results from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy
NDIANAPOLIS, Dec. 11, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that The New England Journal of Medicine has published peer-reviewed results from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The Phase 3 study included 1,033 patients from 67 trial sites in eight countries. These results support the emergency use authorization (EUA) issued by the U.S. Food and Drug Administration (FDA) on Nov. 19 for baricitinib in combination with remdesivir in hospitalized patients with COVID-19 requiring supplemental oxygen.
Dec 31, 2020 02:58 PM WORLD
Singapore Begins Covid Vaccinations as One of Asia’s First
About Veklury®
Veklury® (remdesivir) is a nucleotide analog invented by Gilead, building on more than a decade of the company’s antiviral research. Veklury has broad-spectrum antiviral activity both in vitro and in vivo in animal models against multiple emerging viral pathogens, including Ebola, SARS, Marburg, MERS and SARS-CoV-2, the virus that causes COVID-19.
https://www.gilead.com/purpose/advancing-global-health/covid-19/about-veklury
December 29, 2020 at 4:30 PM EST
REGENERON ANNOUNCES ENCOURAGING INITIAL DATA FROM COVID-19 ANTIBODY COCKTAIL TRIAL IN HOSPITALIZED PATIENTS ON LOW-FLOW OXYGEN
TARRYTOWN, N.Y., Dec. 29, 2020 /PRNewswire/ --
Phase 3 program in hospitalized patients to continue based on passing futility analysis on ability to reduce incidence of death or mechanical ventilation
As in earlier outpatient trial, immune status when patients entered the trial was a strong predictor of viral load and clinical outcomes
First antibody therapy to demonstrate anti-viral effect in patients hospitalized with COVID-19
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
December 17, 2020 at 5:00 PM EST Back
NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES POSITIVE INITIAL REGENERON ANTIBODY COCKTAIL RESULTS IN NON-HOSPITALIZED PATIENTS WITH COVID-19
TARRYTOWN, N.Y., Dec. 17, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19.
Hong Kong fourth wave: city finally secures enough Covid-19 vaccines to cover all residents after striking deal with AstraZeneca
Government has now procured 22.5 million doses, city leader Carrie Lam reveals as she urges everyone to get shots
Indemnity fund to provide help to those who develop rare and serious responses after being vaccinated, but officials say the programme is safe
Phila Siu , Lilian Cheng and Elizabeth Cheung
China promises free jabs for all as Sinopharm’s Covid-19 vaccine approved
The approval comes with conditions but regulator is confident the vaccine is safe and effective
National Health Commission says the shot is a ‘public good’ and will be provided to national inoculation programme
Zhuang Pinghui in Beijing and Simone McCarthy Published: 12:00pm, 31 Dec, 2020
China grants conditional market approval for its first homemade COVID-19 vaccine
By Leng Shumei, Hu Yuwei and Zhang Hui Published: Dec 31, 2020 10:11 AM Updated: Dec 31, 2020 04:11 PM
Coronavirus: Turkey says China’s CoronaVac vaccine 91.25 per cent effective
Health minister says results are first to be released for the Sinovac product; the firm recently delayed an announcement to consolidate data from global trials
Turkey is expecting a shipment of 3 million doses on Monday, as part of a deal for 50 million doses
Associated Press Published: 2:44am, 25 Dec, 2020
Covid: Post-exposure antibody protection trialled
By Rachel Schraer
Health reporter
Ten people have been given antibodies as a form of emergency protection after being exposed to coronavirus, in the first trial of its kind.
https://www.bbc.com/news/health-55438758
To the participants in our COVID-19 vaccine trial around the world: Thank You.
DECEMBER 23, 20203:23 PMUPDATED 17 HOURS AGO
Federal judge blocks Trump administration drug pricing rule
By Brendan Pierson (Reuters) -
Coronavirus: what we know so far about the new strain of Covid-19
•Dec 23, 2020
South China Morning Post South China Morning Post
Coronavirus updates: Third state identifies more transmissible variant as U.S. cases surpass 20 million
By Marisa Iati Jan. 1, 2021 at 1:49 p.m. EST
https://www.washingtonpost.com/nation/2021/01/01/coronavirus-covid-updates/
#ABCNews #COVID19 #NewCoronavirusVariant
What we know about new COVID-19 variant detected in UK l GMA
•Dec 24, 2020
ABC News ABC News
Prognosis
New Virus Strain Fears; Tokyo Battles Spread: Virus Update
Bloomberg News December 30, 2020, 6:15 PM EST Updated on December 31, 2020, 7:54 AM EST
Jan 02, 2021 07:34 PM
China Confirms First British Covid-19 Variant in Shanghai
By Lu Zhenhua
The U.S. needs to identify mutant strains faster: Dr. Peter Hotez
•Jan 4, 2021
CNBC Television Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, says he is conducting research to neutralize a new South African Covid-19 variant. He says the U.S. needs to identify mutant strains faster to tackle this problem.
States in the West and South have the highest shares of residents hospitalized as Los Angeles hospitals turned away ambulances. By Fenit Nirappil and William Wan
Astra-Oxford Covid-19 Vaccine Gets U.K. Clearance
•Dec 30, 2020
Bloomberg Markets and Finance Bloomberg Markets and Finance
How the Pfizer-BioNTech COVID-19 vaccine was developed
•Dec 20, 2020
60 Minutes 60 Minutes
Dr Li Wenliang
Dr. Li Wenliang
Coronavirus: tributes pour in for Li Wenliang, the Chinese doctor who first warned of a deadly disease
‘I hope in the future there will be fewer dead heroes, and more normal, great, everyday people,’ social media user says
‘Our attention then was still on saving the sufferers, we didn’t expect that someone as young as him wouldn’t be able to survive,’ Wuhan doctor Ai Fen says
William Langley Published: 11:30pm, 30 Dec, 2020
Prior news-reports below
Coronavirus: Wuhan police apologise to family of whistle-blowing doctor Li Wenliang
- Medic’s death sparked national outrage after he was disciplined for warning colleagues about early cases of Covid-19
- City’s force says two officers have been disciplined after a report by a team from Beijing blamed a local station for mishandling the case
Keegan Elmer in Beijing Published: 8:18pm, 19 Mar, 2020
Li Wenliang: Coronavirus kills Chinese whistleblower doctor
- 7 February 2020
https://www.bbc.com/news/world-asia-china-51403795
BACKCHANNEL05.01.2020 07:00 AM
Inside the Early Days of China’s Coronavirus Coverup
The dawn of a pandemic—as seen through the news and social media posts that vanished from China’s internet.
Coronavirus: Whistle-blower Dr Li Wenliang confirmed dead of the disease at 34, after hours of chaotic messaging from hospital
- Li was one of the first doctors who tried to share information about the coronavirus only to be reprimanded by Wuhan police
- Wuhan Central Hospital initially denied reports he was dead, saying he was in ‘critical condition’, before finally confirming he had died
Cissy Zhou Published: 12:05am, 7 Feb, 2020
Li Wenliang: an ‘ordinary hero’ at the centre of the coronavirus storm
- In a self-criticism to his employer, Li said he had no authority to ‘release inaccurate information’
- He promised to keep in line with the Communist Party ‘in thought and action’
Guo Rui in Guangzhou and Jane Cai
Published: 11:00am, 15 Feb, 2020
Chinese doctor who sounded the alarm on coronavirus dies of the illness
BY SOPHIE LEWIS
FEBRUARY 6, 2020 / 4:09 PM / CBS NEWS
China Announces That It Will Expel American Journalists
The announcement comes weeks after President Trump limited the number of Chinese citizens who can work in the United States for five state-run Chinese news organizations.
SHAWN YUAN BACKCHANNEL05.01.2020 07:00 AM
Inside the Early Days of China’s Coronavirus Coverup
The dawn of a pandemic—as seen through the news and social media posts that vanished from China’s internet.
That day, a Wuhan doctor named Li Wenliang—a whistleblower who had raised alarms about the virus in late December, only to be reprimanded for “spreading rumors”—died of Covid-19.
Within hours, his death sparked a spectacular outpouring of collective grief on Chinese social media—an outpouring that was promptly snuffed out, post by post, minute by minute. With that, grief turned to wrath, and posts demanding freedom of speech erupted across China’s social media platforms as the night went on.
biotecMAX™
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
Biotech-WAR$™-God, Turn It Around 上帝，把它转过来
Dec. 8, 2020 8:08 PM ET| About: AbbVie Inc. (ABBV), AMGN, AZN, BGNE, GILD, GSK, JNJ, MRK, PFE
Summary
The unfortunate truth is the biotech-WAR$ are never-ending.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV) since September.
The worldwide response to this virus has been a colossal failure. America's response to this virus has been horrific.
hyperinflation is already here.
https://seekingalpha.com/instablog/5205071-danwatson888/5529720-biotech-war-god-turn-around
Thank you for visiting biotecALPHA™
Thank you fior visiting biotecHEART™
BiotecNOVA™ Running to the LIGHT
BiotecNOVA™ Running To The Light
Nov. 15, 2020 7:57 AM ET| About: Amgen Inc. (AMGN), AZN, BMY, BNTX, GSK, JNJ, LLY, MRK, MRNA, NVS, PFE, RHHBY,
Summary
“When you get on a plane everyone routes for the pilot”.
Pfizer (PFE) and Lilly (LLY) remain two of my top holdings.
Unfortunately for the state of Georgia, they will be subjected to countless new political ads for those competing for the two GA Senate races that will determine which party controls.
There have been many positive news articles on successful meds directed to cancer and other ailments just within the past 3 weeks.
Thank you for visiting biotecNOVA™
Thank you for visiting biotecDATA™
See A Victory – BiotecMAX™
See A Victory – BiotecMAX™
Oct. 24, 2020 3:08 PM ET |About: AbbVie Inc. (ABBV), AMGN, AZN, BMRN, BMY, BNTX, DXCM, EXEL, GILD, GLPG, GSK, JNJ, LLY, MDT, MRK, MRNA, PFE, SGEN
Summary
Unfortunately the Covid-19 virus is not over.
During the recent downturn I voted to increase my positions in (AMGN) (ABBV) (JNJ) (GILD) (MRK).
We all need to understand BSL-4 Labs and confirmation of the origins of the Covid-19 virus.
I remain hopeful that politicos will go after bigger fish before they target the biotech/pharma companies.
https://seekingalpha.com/instablog/5205071-danwatson888/5512633-see-victory-biotecmax
Thank you for visiting biotecMAX™
On August 1, 2020 I started the third full page of information and updates on Covid-19/SARS CoV2.
I never thought that this www.BioHazard2020.com would result in a third full page, but it does.
My first virus posting on this site was on January 11, 2020 ( https://seekingbiotechalpha.com/2020-1 ) =
https://www.scmp.com/news/hong-kong/health-environment/article/3045750/wuhan-pneumonia-hong-kong-set-develop-new-test and https://www.caixinglobal.com/2020-01-11/first-death-from-new-sars-like-virus-reported-in-central-chinas-wuhan-101503267.html
Welcome to BiotecHOPE™ and thank you for visiting www.biotechope.com.
BiotecHOPE™
There are many new medicines in testing, development and clinical trials that are currently not available or recently approved to the marketplace and many are having encouraging and positive results. There are also many approved meds that are in tests involved for other ailments/conditions that might work, where these new trials will determine. BiotecHOPE™ will seek to highlight these trials/efforts many of which are from smaller/newer biotech companies and/or are being developed by/with Universities or Hospitals.
Welcome to BiotecHOPE™ and thank you for visiting www.biotechope.com.
Thank you for visiting biotecMAX ™
biotecMAX™ Run To The Father
Sep. 28, 2020 9:38 AM ET| About: Johnson & Johnson (JNJ)
Summary
And just like that the biotech-WAR$™ are back in full force.
(JNJ) is one of my top holdings and I have been adding shares during this recent downturn.
There have been many positive and encouraging biotech news events during this one month = September 2020.
Abortion is a forever and lasting evil. Abortion is total annihilation.
https://seekingalpha.com/instablog/5205071-danwatson888/5512633-see-victory-biotecmax
Thank you for visiting biotech-WARS™
Thank you for visiting biotechVORTEX™
biotecMAX™
miracle on ice milagro sobre hielo 冰上的奇迹
The World’s Most Loathed Industry Gave Us a Vaccine in Record Time
At least one thing went right in 2020: Pharmaceutical companies came through. Thank you, science.
PHOTOGRAPHER: IAN LORING SHIVER FOR BLOOMBERG BUSINESSWEEK; PROP STYLIST: DAVID PROBASCO
By Drew Armstrong
Tracking the Spread of the Coronavirus Outbreak in the U.S. Updated: December 15, 2020, 3:30 PM EST
COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
Sep. 11, 2020 7:23 PM ET|
About: AbbVie Inc. (ABBV), Includes: ABT, AMGN, AZN, BGNE, BMY, BNTX, GSK, JNJ, LLY, MDT, MRK, MRNA, NVS, PFE, RHHBY, SNY, TMO
Summary
politicos have started again to bash biotech/pharma/healthcare companies all in an effort to gain votes and yes even during a pandemic.
Meanwhile, Biotech/pharma/med-tech companies have made significant progress in non-covid-19 medicines covering many other ailments.
AbbVie is one of my top holdings and I have been adding shares during the recent September downturn.
noteworthy positive news events over the last 2 months regarding both Covid-19 and non-Covid-19 partnerships, collaborations, mergers and acquisitions are in progress.
https://seekingalpha.com/instablog/5205071-danwatson888/5496262-biotecmax-you-keep-hope-alive
Pfizer-BioNTech COVID-19 vaccine
PFIZER AND BIONTECH TO SUPPLY THE EUROPEAN UNION WITH 100 MILLION ADDITIONAL DOSES OF COMIRNATY®
Tuesday, December 29, 2020 - 01:11pm
- European Union orders 100 million additional doses of COMIRNATY® bringing total doses to 300 million for 27 EU member states
- All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005380/en/
PFIZER AND BIONTECH CELEBRATE HISTORIC FIRST AUTHORIZATION IN THE U.S. OF VACCINE TO PREVENT COVID-19
Friday, December 11, 2020 - 11:12pm
- U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediately
- Pfizer and BioNTech previously announced an agreement with the U.S. Government to supply doses in 2020 & 2021
- In collaboration with Operation Warp Speed, Pfizer and BioNTech, as well as other vaccine companies are expected to deliver hundreds of millions of vaccine doses to Americans by the end of 2021
- Historic science-driven efforts will seek to help bring an end to the most devastating pandemic in a century
- Pfizer and BioNTech expect to file a Biologics License Application for possible full regulatory approval in 2021
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of the mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. The vaccine is now authorized under an Emergency Use Authorization (EUA) while Pfizer and BioNTech gather additional data and prepare to file a planned Biologics License Application (BLA) with the FDA for a possible full regulatory approval in 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201211005640/en/
Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
- U.S. government orders 100 million additional doses of the Pfizer-BioNTech COVID-19 vaccine bringing total doses for U.S. to 200 million
- All 200 million doses will be produced by U.S. manufacturing facilities and are expected to be delivered by July 31, 2021, allowing for 100 million people in the U.S. to be vaccinated
NEW YORK and MAINZ, GERMANY, December 23, 2020 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the original agreement announced in July 2020, the U.S. government will pay $1.95 billion for the additional 100 million doses.
https://seekingalpha.com/symbol/PFE
https://seekingalpha.com/symbol/BNTX
Prognosis
The bloc is pursuing a deal that could double its Pfizer shot supply.
Prognosis
NEWS/ An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
AN IN VITRO STUDY SHOWS PFIZER-BIONTECH COVID-19 VACCINE ELICITS ANTIBODIES THAT NEUTRALIZE SARS-COV-2 WITH A MUTATION ASSOCIATED WITH RAPID TRANSMISSION
Friday, January 08, 2021 - 12:00am
New York, NY and Mainz, Germany, January 8, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains. The results were published on the preprint server bioRxiv and are available here.
Prognosis
Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2 vaccine)
Moderna COVID-19 Vaccine
GO TO FULL UNITED STATES SITE HERE:
For US Vaccination ProvidersFor US Vaccine Recipients
- The Moderna COVID‑19 Vaccine has not been approved or licensed by the US Food and Drug Administration (FDA), but has been authorized for emergency use by FDA, under an Emergency Use Authorization (EUA), to prevent Coronavirus Disease 2019 (COVID‑19) for use in individuals 18 years of age and older. There is no FDA-approved vaccine to prevent COVID‑19.
- The EUA for the Moderna COVID‑19 Vaccine is in effect for the duration of the COVID‑19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.
- https://www.modernatx.com/
Health Canada Authorizes Moderna COVID-19 Vaccine in Canada
December 23, 2020 at 11:20 AM ESTPDF Version
Authorization under Health Canada's Interim Order
Canadian government has secured 40 million doses
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 23, 2020-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order.
U.S. CDC Advisory Committee on Immunization Practices Recommends Vaccination with Moderna’s COVID-19 Vaccine for Persons 18 Years and Older
December 19, 2020 at 9:44 PM ESTPDF Version
Recommendation follows yesterday’s U.S. FDA authorization for emergency use of the Moderna COVID-19 Vaccine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 19, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Moderna COVID-19 vaccine in people 18 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA). The committee is comprised of independent health experts. 11 ACIP members voted in favor of the vaccine and 0 members voted against.
https://seekingalpha.com/symbol/MRNA
Contracts For Dec. 28, 2020
Moderna US Inc., Cambridge, Massachusetts, was awarded a $1,966,598,000 modification (P00003) to contract W911QY20C0100 for purchase of an additional 100 million filled drug production doses of SARS-CoV-2 mRNA-1273 vaccine utilizing Option 1 and acetate efforts on the base and option. Work will be performed in Cambridge, Massachusetts, with an estimated completion date of June 30, 2021. Fiscal 2021 research, development, test and evaluation funds in the amount of $1,966,598,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded Dec. 11, 2020)
Moderna secures $1.97B Army contract modification for COVID-19 vaccine doses
Dec. 28, 2020 11:43 PM ETModerna, Inc. (MRNA)By: Mamta Mayani, SA News Editor17 Comments
- Moderna (NASDAQ:MRNA
Prognosis
biotecHOPE™ Won’t Stop Now
biotecHOPE™ Won’t Stop Now
Aug. 26, 2020 5:37 PM ET
|About: AstraZeneca PLC (AZN), BNTX, CYDY, GILD, GSK, MRK, NVAX, PFE, SNY
Summary
"The country behaved like a horror-movie character who believes the danger is over, even though the monster is still at large."
there is encouraging news coming from biotech/pharma companies with regard to vaccines and therapies to fight this virus.
"I know breakthrough is coming, By faith I see a miracle
My God made me a promise, And it won't stop now"
https://seekingalpha.com/instablog/5205071-danwatson888/5489657-biotechope-won-t-stop-now
To the participants in our COVID-19 vaccine trial around the world: Thank You.
Thank you for making a difference.
We are grateful to the tens of thousands of courageous people who chose to volunteer for the COVID-19 Vaccine Study.
Pfizer/BioNTech to speed up vaccination of placebo arm in COVID-19 trial
Jan. 02, 2021 2:54 AM ET Pfizer Inc. (PFE) By: Dulan Lokuwithana, SA News Editor19 Comments
https://seekingalpha.com/news/3648181-pfizer-biontech-to-speed-up-vaccination-of-placebo-arm-in-covidminus-19-trial
https://www.pfizer.com/
https://seekingalpha.com/symbol/PFE
https://seekingalpha.com/symbol/BNTX
A Look Back At Covering The Coronavirus Pandemic: ‘Unlike Anything I’d Experienced’ | Sunday TODAY
•Dec 27, 2020
TODAYTOD AY
biotecNOVA™ - Let The Light In
biotecNOVA™ - Let The Light In
Jul. 11, 2020 12:00 PM ET
|About: Amgen Inc. (AMGN), BGNE, GILD, GSK, NVAX, PFE, AZN, JNJ
Summary
some encouraging biotech news events and hopeful USA investments in vaccine development and anti-viral development.
The number of Covid-19 cases in the USA is the highest in the world and getting worse.
a temporary truce between politicos and the biopharma community.
if there is a business sector that can unite Americans, Europeans and Chinese more than any other sector it is the biotech sector.
https://seekingalpha.com/instablog/5205071-danwatson888/5471018-biotecnova-let-light-in
BioHazard2020 biotech-WARS™ biotecNOVA™ (Danwatsonblogs)
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
Revival’s In The Air–BiotecWARS™
Revival’s In The Air–BiotecWARS™
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
Revival’s In The Air–BiotecWARS™
Revival’s In The Air–BiotecWARS™
Jan. 20, 2021 7:10 PM ET|
About: AbbVie Inc. (ABBV), AZN, BGNE, BMRN, BMY, BNTX, JNJ, LLY, MRK, MRNA, PFE, RHHBY, SGEN
Summary
After a storm sometimes skies become clearer.
Many companies are now considering or have already concluded that they will no longer fund politicos, either all of them, or some of them.
“The World’s Most Loathed Industry Gave Us a Vaccine in Record Time”.
I have been adding long positions in (MRK) (GILD) (AMGN) (JNJ) (ABBV) (AZN) since September 2020 to the SeekingBiotechAlpha portfolio.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5545353-revival-s-in-air-biotecwars
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
Biotech-WAR$™-God, Turn It Around 上帝，把它转过来
Dec. 8, 2020 8:08 PM ET|About: AbbVie Inc. (ABBV), AMGN, AZN, BGNE, GILD, GSK, JNJ, MRK, PFE
Summary
The unfortunate truth is the biotech-WAR$ are never-ending.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV) since September.
The worldwide response to this virus has been a colossal failure. America's response to this virus has been horrific.
hyperinflation is already here.
https://seekingalpha.com/instablog/5205071-danwatson888/5529720-biotech-war-god-turn-around
BiotecNOVA™ Running to the LIGHT
BiotecNOVA™ Running to the LIGHT
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
BiotecNOVA™ Running To The Light
Nov. 15, 2020 7:57 AM ET| About: Amgen Inc. (AMGN), AZN, BMY, BNTX, GSK, JNJ, LLY, MRK, MRNA, NVS, PFE, RHHBY, SNY
Summary
“When you get on a plane everyone routes for the pilot”.
Pfizer (PFE) and Lilly (LLY) remain two of my top holdings.
Unfortunately for the state of Georgia, they will be subjected to countless new political ads for those competing for the two GA Senate races that will determine which party controls.
There have been many positive news articles on successful meds directed to cancer and other ailments just within the past 3 weeks.
See A Victory – BiotecMAX™
BiotecNOVA™ Running to the LIGHT
biotecMAX™ Run To The Father
See A Victory – BiotecMAX™
Oct. 24, 2020 3:08 PM ET |About: AbbVie Inc. (ABBV), AMGN, AZN, BMRN, BMY, BNTX, DXCM, EXEL, GILD, GLPG, GSK, JNJ, LLY, MDT, MRK, MRNA, PFE, SGEN
Summary
Unfortunately the Covid-19 virus is not over.
During the recent downturn I voted to increase my positions in (AMGN) (ABBV) (JNJ) (GILD) (MRK).
We all need to understand BSL-4 Labs and confirmation of the origins of the Covid-19 virus.
I remain hopeful that politicos will go after bigger fish before they target the biotech/pharma companies.
biotecMAX™ Run To The Father
BiotecNOVA™ Running to the LIGHT
biotecMAX™ Run To The Father
biotecMAX™ Run To The Father
Sep. 28, 2020 9:38 AM ET|
About: Johnson & Johnson (JNJ)
Summary
And just like that the biotech-WAR$™ are back in full force.
(JNJ) is one of my top holdings and I have been adding shares during this recent downturn.
There have been many positive and encouraging biotech news events during this one month = September 2020.
Abortion is a forever and lasting evil. Abortion is total annihilation.
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
Sep. 11, 2020 7:23 PM ET|About: AbbVie Inc. (ABBV), Includes: ABT, AMGN, AZN, BGNE, BMY, BNTX, GSK, JNJ, LLY, MDT, MRK, MRNA, NVS, PFE, RHHBY, SNY, TMO
Summary
politicos have started again to bash biotech/pharma/healthcare companies all in an effort to gain votes and yes even during a pandemic.
Meanwhile, Biotech/pharma/med-tech companies have made significant progress in non-covid-19 medicines covering many other ailments.
AbbVie is one of my top holdings and I have been adding shares during the recent September downturn.
noteworthy positive news events over the last 2 months regarding both Covid-19 and non-Covid-19 partnerships, collaborations, mergers and acquisitions are in progress.
Inside the Clash Between Powerful Business Leaders and N.Y.C.’s Mayor
The tensions burst into the open when 163 executives joined to criticize Bill de Blasio’s leadership. Others think their portrait of the city is overly bleak.
By J. David Goodman, Emma G. Fitzsimmons and Jeffery C. Mays
Sept. 12, 2020Updated 10:29 a.m. ET
https://www.nytimes.com/2020/09/12/nyregion/coronavirus-business-nyc-reopen.html
biotecHOPE™ Won’t Stop Now
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
biotecHOPE™ Won’t Stop Now
Aug. 26, 2020 5:37 PM ET|About: AstraZeneca PLC (AZN), BNTX, CYDY, GILD, GSK, MRK, NVAX, PFE, SNY
Summary
"The country behaved like a horror-movie character who believes the danger is over, even though the monster is still at large."
there is encouraging news coming from biotech/pharma companies with regard to vaccines and therapies to fight this virus.
biotecNOVA™ - Let The Light In
biotecMAX™ You Keep Hope Alive
BioHazard2020 I Will Fear No More
biotecNOVA™ - Let The Light In
Jul. 11, 2020 12:00 PM ET|About: Amgen Inc. (AMGN), BGNE, GILD, GSK, NVAX, PFE, AZN, JNJ
Summary
some encouraging biotech news events and hopeful USA investments in vaccine
development and anti-viral development.
The number of Covid-19 cases in the USA is the highest in the world and getting worse.
a temporary truce between politicos and the biopharma community.
if there is a business sector that can unite Americans, Europeans and Chinese more than any other sector it is the biotech sector.
BioHazard2020 I Will Fear No More
Biotech-WAR$™ Biohazard2020 Peace Be Still
BioHazard2020 I Will Fear No More
BioHazard2020 I Will Fear No More
Jun. 9, 2020 5:29 PM ET|About: AbbVie Inc. (ABBV), AZN, BMY, GILD, GSK, MRK, MRNA, RHHBY
Summary
We seem to have entered into what I’ll call the “404 Pandemic”.
significant positive product news on the medical biotech front during May & June 2020.
The Camden NJ waterfront and the city of Camden NJ has come a long way from where it was, but it has taken many years to achieve it’s current level.
Many segments of American cities population were already disconnected from the economic growth and success in America.
The Importance of Placemaking.
Biotech-WAR$™ Biohazard2020 Peace Be Still
Biotech-WAR$™ Biohazard2020 Peace Be Still
Biotech-WAR$™ Biohazard2020 Peace Be Still
Biotech-WAR$™ Biohazard2020 Peace Be Still
May 11, 2020 1:11 PM ET|About: Amgen Inc. (AMGN), BGNE, BMY, LLY, REGN, VIR, WXXWY
Summary
staggering and growing rift between the world’s 2 economic powerhouses.
there are some China based biotech companies that should be considered as strong investments going forward.
biotech investments are critical and important for the health of all countries.
at this point I do not think the origins of the virus matter much as the USA/China relationship could not get much worse.
BioHazard2020 Won’t Stop Now
Biotech-WAR$™ Biohazard2020 Peace Be Still
Biotech-WAR$™ Biohazard2020 Peace Be Still
BioHazard2020 Won’t Stop Now
May 5, 2020 5:34 AM ET|About: AstraZeneca PLC (AZN), BNTX, GSK, JNJ, PFE, SNY
Summary
The unfortunate truth is that the COVID-19 virus, will not just go away.
many vaccine candidates are in progress/development/clinical trials.
The virus continues to work its utmost damage among us all.
there is a now a new Biotech-War$ emerging and it is more complicated then the original.
BIOTECH$TORM™ BIOTECH-WAR$™ BiotecHEART™ (Danwatsonblogs)
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
Apr. 23, 2020 2:02 PM ET| About: Incyte Corporation (INCY), Includes: A, ABBV, AMGN, BDX, BMY, GILD, IMMU, LH, LLY, MDT, MRK, MRNA, NVO, NVS, RHHBY, SGEN, TMO, VIR
Summary
11 states should create a new entity = Biotechnology States of America.
Covid-19 remains a riddle, wrapped in a mystery, inside an enigma.
The political storm created by the Covid-19 virus is very real.
The economic and human loses from this event will impact America and the world for a long time.
Ruxolitinib (Jakafi®) may help prevent another complication of Covid-19.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
BioHazard2020™ Weapon
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020™ Weapon
Apr. 14, 2020 6:24 AM ET|
About: Gilead Sciences, Inc. (GILD), JNJ, PFE
Summary
there is no evidence that the novel coronavirus (2019-nCoV) now known as = COVID-19 is or was created from a biological weapons lab or any virology lab anywhere.
There is hope with one new med previously intended for another disease – Ebola.
Remdesivir (GS-5734, Nuc inhibitor).
Thankfully there are many companies that are developing vaccines for COVID-19.
The virus is “simply a piece of bad news wrapped up in protein,”.
https://seekingalpha.com/instablog/5205071-danwatson888/5433549-biohazard2020-weapon
Long Only, Deep Value, Dividend Growth Investing, Healthcare
Biohazard2020™ Not Done Yet
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
Biohazard2020™ Not Done Yet
Biohazard2020™ Not Done Yet
Apr. 5, 2020 9:48 AM ET |About: Abbott Laboratories (ABT), GILD, MDT
Summary
Politico's continue to offer confusion, misinformation, and misdirection.
Hope = Remdesivir.
One of the more intriguing news events during this virus pandemic is the simultaneous crisis in the oil sector.
New Jersey governor calls for 'postmortem' of federal response to coronavirus.
Biohazard2020™ Not Done Yet
Apr. 5, 2020 9:48 AM ET|About: Abbott Laboratories (ABT), GILD, MDT
https://seekingalpha.com/instablog/5205071-danwatson888/5429826-biohazard2020-not-done-yet
Biotech-War$ Burn The Ships
Biotech-Wars™ – Hunger + Thirst
Biohazard2020™ Not Done Yet
Biotech-War$ Burn The Ships
Mar. 27, 2020 3:47 PM ET|About: Gilead Sciences, Inc. (GILD), Includes: JNJ, MRNA, RHHBY, VIR
Summary
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
The virus was the pin the popped the highly leveraged and overconfident market that many were indicating/predicting needed some adjustment. But not many were forecasting a -37% “pin” reduction vs.Jan.
an antiviral drug is a virus suppressant that blocks the chemical compounds that the virus needs for replication, its goal is to reduce the number of virus counts in the body to a manageable state.
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
Feb. 29, 2020 12:46 PM ET
|About: AbbVie Inc. (ABBV), GILD, JNJ, MRNA, REGN, VIR, WXXWY
Summary
the news coming from China since January 11, 2020 was never positive even if the actual reported statistical data was suspect.
everyone, including everyone in China, has a right to be angry about COVID-19.
too much single source product manufacturing located in China.
politicos are now creating “Anti-Endorsements” lists that identify successful USA citizens.
BiotecHeart™ - See The Light
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
BiotecHeart™ - See The Light
Feb. 20, 2020 10:20 AM ET|About: Amarin Corporation plc (AMRN), BMY, DBX, GILD, JNJ, MRK, NVO, NVS, PFE, RHHBY, ABBV
Summary
The political and socio-economic environment in America, is both depressing and disconcerting.
The hostility increases towards everyone connected with the biotech/drug industry during this highly politically charged season.
Politicos still see little to no value in biotech companies and continue to vilify them.
There continues to be much encouraging news and positive clinical tests in the biotech world, including on the coronavirus situation, for the first 2 months of 2020.
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ Joy Unto The World
Dec. 24, 2019 6:27 AM ET
Summary
this has been the “Biotech Decade” 2010-2019.
this year has been the “Biotech Year”.
Based on the current political environment it has been a spectacular year for the healthcare sector, and for many biotech companies.
|About: AbbVie Inc. (ABBV), ABMD, ABT, AMGN, AMRN, AZN, BGNE, BIIB, BLUE, BMRN, BMY, GILD, ISRG, JNJ, LLY, MDT, MRK, NVS, PFE, REGN, RHHBY, SGEN, SRPT, VRTX
Biotech-WAR$™-Biohazard 2020
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ “Joy Unto The World”
Biotech-WAR$™-Biohazard 2020
Dec. 15, 2019 4:18 PM ET|
Summary
the biotech sector is essentially avoided, at least publicly, as a recommended investment sector.
the 2020 political BiotechSTORM is coming.
I guess that If you can’t get anyone on TV to make positive comments on biotech companies then the sector must not be well liked or a good investment?
I guess the biotech/medtech successes for the past 10 years are and will remain a secret success story and a bewildering anomaly?
There has been “Nothing Else” but biotech success stories this December 2019 as there have been the entire year of 2019.
This has been the BIOTECH DECADE -2010-2019.
Biotech-WAR$™-Biohazard 2020
Dec. 15, 2019 4:18 PM ET|About: AbbVie Inc. (ABBV), ABMD, AMGN, AMRN, AZN, BIIB, BLUE, BMY, CELG, GILD, IBB,
BiotecNOVA™ All That Matters
BiotecHeart™ “Joy Unto The World”
Biotech-Wars™ Counteroffensive
BiotecNOVA™ All That Matters
Dec. 31, 2019 4:20 PM ET
Summary
this has been the BIOTECH Decade.
10 years of phenomenal clinical success stories in many areas and that is “All That Matters".
And this year 2019 has been a great year for the entire biotech sector.
AbbVie Inc. (ABBV), ABMD, ABT, AMGN, AMRN, AZN, BGNE, BIIB, BLUE, BMRN, BMY, GILD, ISRG, JNJ, LLY, MDT, MRK, NVS, PFE, REGN, RHHBY, SGEN, SRPT, VRTX
Biotech-Wars™ Counteroffensive
Biotech-War$ - The “Morally” Correct Mandate
Biotech-Wars™ Counteroffensive
Biotech-Wars™ Counteroffensive
Sep. 18, 2019 2:46 PM ET|About: Johnson & Johnson (JNJ)
Summary
politicos have made a massive mistake vilifying the biotech sector.
politicos continue to see the biotech sector as easy targets in an effort to gain votes and win elections.
It is time for all biotech companies to take counteroffensive measures.
In a year that the biotech sector has been totally maligned by politicos, biotech companies will again achieve outstanding medical success as they did in 2018. I remain 100% invested in biotech and medtech companies as of 9/18/2019. And I remain long (JNJ).
Biotech-War$ - The “Morally” Correct Mandate
Biotech-War$ - The “Morally” Correct Mandate
Biotech-War$ - The “Morally” Correct Mandate
Biotech-War$ - The “Morally” Correct Mandate
Sep. 9, 2019 10:10 AM ET|About: Johnson & Johnson (JNJ)
Summary
candidates now see political socialism as the “morally” correct mandate,
a significant block of voters seem to want much more and expect much more from their government.
Nevertheless, and while under attack, biotech companies continue to bring successful products to market.
I am re-investing my biotech dividends back into additional shares of the following companies; (PFE), (JNJ), (LLY), (MRK), (AMGN), (BMY), (AZN), (ABBV), (MDT), (CELG), (GILD), (NVS), (OTCQX:RHHBY)
Biotech-War$-Champions Of The World
Biotech-War$ - The “Morally” Correct Mandate
Biotech-War$ - The “Morally” Correct Mandate
.
Biotech-War$-Champions Of The World
Sep. 4, 2019 12:51 PM ET|About: Amgen Inc. (AMGN), AZN, BMY, JNJ, MRK, PFE, Includes: ABBV, LLY
Merck Foundation Launches Five-Year Initiative to Reduce Disparities in HIV Care for Vulnerable and Underserved Southeastern US Communities.
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults Leiden, The Netherlands, September 3, 2019 –.
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (RCC).
BIOTECH$TORM™ BIOTECH-WAR$™ BiotecHEART™ (Danwatsonblogs)
Biotech-War$™-Be Fine & Dream-Dream-Dream
BiotecHEART™-Breakthrough
BiotecHEART™-Breakthrough
Biotech-War$™-Be Fine & Dream-Dream-Dream
BiotecHEART™-Breakthrough
BiotecHEART™-Breakthrough
Dec. 9, 2019 8:35 AM ET|About: AbbVie Inc. (ABBV), ALPMY, BMY, CELG, JNJ, MRK, PFE, RHHBY, SGEN
Summary
There is no impossible.
2019, has been a breakthrough year for all who need medicine.
many clinical tests involving combinations of successful medicines.
many approvals this year in China for successful medicines.
Biotech-War$™-Be Fine & Dream-Dream-Dream
Biotech-War$™-Be Fine & Dream-Dream-Dream
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™-Be Fine & Dream-Dream-Dream
Dec. 4, 2019 2:20 PM ET|About: Alphabet Inc. (GOOGL), Includes: BMY, JNJ, MRK, PFE, RHHBY, SGEN
Summary
politicos miss the real underlying support for the companies in the biotech/drug sector = medicine that brings about positive and encouraging outcomes, medicine that brings about successful outcomes.
The biotech/medtech success stories for all of November & early December 2019 are remarkable.
But it is not just the biotech sector that is under attack, big USA tech companies remain targets.
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Nov. 23, 2019 8:40 PM ET|About: Bristol-Myers Squibb Company (BMY), CELG, Includes: AMRN, JNJ, MRK, NVO, NVS, PFE, RHHBY
Summary
For me the world is upside down when success and profit and shareholders and new medicines and new medical devises and new products are vilified, this is insanity.
New Jersey is the “Biotech State”.
Unfortunately, the Biotech-War$™ continue in November 2019 and continue to expand at a high speed towards encompassing many other WAR$ against new business sectors.
But please don’t tell any Politicos about these biotech victories below they would not understand these remarkable events – just read them At Your Whisper, shhh….
“Let’s show them we are better”.
Biotech-War$™ - ZOMBIES TARGET ALPHA & HOPE
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ - ZOMBIES TARGET ALPHA & HOPE
Biotech-WAR$ - ZOMBIES TARGET ALPHA & HOPE
Nov. 14, 2019 9:50 PM ET|About: Amarin Corporation plc (AMRN), BMY, MRK, PFE
Summary
“POLITICAL ZOMBIES” and are now fully targeting ALPHA.
Zombies create “Irrational FEAR”, they thrive on “Irrational FEAR”
.
HOPE is a mechanism developed by the human brain to cope with contexts and situations unfavorable to survival.
HOPEFUL news events, many are even remarkable, in the Biotech and MedTech sectors in just the first 14 days of November 2019 and they WON'T STOP NOW.
Biotech-War$™ - Raise A Hallelujah
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ - ZOMBIES TARGET ALPHA & HOPE
Biotech-WAR$ - Raise A Hallelujah
Nov. 9, 2019 6:45 PM ET|About: AbbVie Inc. (ABBV), ABMD, ABT, AGN, AMGN, AMRN, AZN, BGNE, BIIB, BMRN, BMY, CELG, GILD, ILMN, ISRG, JNJ, LLY, MDT, MRK, NVO, NVS, PFE, REGN, RHHBY, SGEN, VAR, VRTX
Summary
Politicos are now simultaneously spearheading Biotech-WAR$™, Tech WARS, and now Class WARS.
The biotech/medtech sectors continue to succeed and are on track to have another banner 2019 both in product development and financial success.
Billionaire Leon Cooperman has had enough and is fighting back.
Google and Facebook and Twitter should all fight back as should every Biotech company, every Bank, every business in the America.
Biotech-War$™ – I See A Victory
Biotech-War$™ – I See A Victory
Biotech-War$™ – I See A Victory
Biotech-Wars – I See A Victory
Oct. 14, 2019 2:38 PM ET|About: Amgen Inc. (AMGN), AZN, BMY, GILD, JNJ, LLY, MRK, PFE, RHHBY, SGEN, MDT
Summary
I see the power of many “Biotech Victory's”. every day.
promote the power of a “Biotech Victory”.
politicos have made a grave mistake vilifying the biotech sector.
Bio-Tech & China, China, China
Biotech-War$™ – I See A Victory
Biotech-War$™ – I See A Victory
Mar. 14, 2018 1:14 PM ET|About: Amgen Inc. (AMGN), AZN, BGNE, CELG, NVS, Includes: ABMD, BMY, LLY, MDT, MRK, NVO
Summary
China Bio-Tech growth is accelerating now.
China needs better healthcare in every province.
China will welcome all bio-technology partnerships.
China is on the verge of major investment changes.
https://seekingalpha.com/instablog/5205071-danwatson888/5127900-bio-tech-china-china-china
Biotech War$-Enemy Of The $Tate
Biotech-War$™ – I See A Victory
Biotech War$-Enemy Of The $Tate
Biotech War$-Enemy Of The $Tate
Oct. 18, 2019 12:50 PM ET|About: AbbVie Inc. (ABBV), AMGN, JNJ, LLY, MRK, VRTX, Includes: AMRN
Summary
Are successful USA based companies now the “enemy of the state”?
Cambridge, Mass. is in my view the epicenter of the biotech industry.
The attacks on all biotech companies will only benefit biotech hubs in Shanghai, China, Basel, Switzerland and Dublin, Ireland all highly supportive biotech centers.
“The inherent vice of capitalism is the unequal sharing of blessings; the inherent virtue of socialism is the equal sharing of miseries.” Winston Churchill
BioTECH! ZONE
BiotecHeart™ - See The Light
Biotech War$-Enemy Of The $Tate
Apr. 2, 2019 8:20 PM ET|About: AstraZeneca PLC (AZN), BMY, CELG, Includes: AMRN, JNJ, MRK, NVO, NVS, PFE, RHHBY, SNY
Summary
“TINSTAAFL” = “There is no such thing as a free lunch”.
Princeton NJ/Central Jersey – is for me the best example of a successful BioTECH Zone.
Ireland's Life Sciences sector has grown from very humble beginnings in the 1960s to reach global significance. Collaborative clusters in Pharmaceutical, Biotechnology, Medical Devices and Diagnostics have been a key.
AstraZeneca is spearheading the creation of a new life sciences park, in Wuxi, China, that aims to nurture innovation.
Cambridge, Mass, is one of the best examples of a successful BioTECH Zone.
HOSANNA
BiotecHeart™ - See The Light
BiotecHeart™ - See The Light
HOSANNA
Nov. 2, 2019 8:29 AM ET|2 comments |About: Amgen Inc. (AMGN), BGNE, BMY, GILD, PFE, SGEN, VRTX, VAR, NVO
Summary
The progress and product successes being achieved in the Biotech sector this September and October 2019 is nothing less than remarkable.remarkable Biotech/MedTech gains in September 2019 and October 2019.In the Hebrew Bible hôšîʿâ-nā is used only in verses such as "help" or "save, I pray" (Psalms 118:25).
In the Hebrew Bible hôšîʿâ-nā is used only in verses such as "help" or "save, I pray" (Psalms 118:25).
https://seekingalpha.com/instablog/5205071-danwatson888/5369912-hosanna
BiotecHeart™ - See The Light
BiotecHeart™ - See The Light
BiotecHeart™ - See The Light
BiotecHeart™ - See The Light
Feb. 20, 2020 10:20 AM ET|About: Amarin Corporation plc (AMRN), BMY, DBX, GILD, JNJ, MRK, NVO, NVS, PFE, RHHBY, ABBV
Summary
The political and socio-economic environment in America, is both depressing and disconcerting.
The hostility increases towards everyone connected with the biotech/drug industry during this highly politically charged season.
Politicos still see little to no value in biotech companies and continue to vilify them.
There continues to be much encouraging news and positive clinical tests in the biotech world, including on the coronavirus situation, for the first 2 months of 2020.
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
SARS-CoV2 - BioHazard2020
The Start of the Coronavirus infection = novel coronavirus (2019-nCoV) = SARS-CoV2 = Covid-19= BioHazard2020
Below is the first section, a 1/2 page, and the start of my coverage of the SARS-CoV2 virus from January 2020 to early April 2020. It was during late February 2020 and early March that I was coming to conclusion that this virus was going to be a worldwide issue for some time - and I started www.biohazard2020.com and dedicated full page sections to the virus. The first date that I became aware of the virus was on January 11, 2020 via three posts noted below, 2 from SCMP and 1 from Caixin Global =
Wuhan pneumonia: Hong Kong set to develop new test for mystery virus after obtaining genetic sequence from mainland China
A team of experts will also fly over to the mainland city to be briefed on the situation and learn about control measures
News comes after China confirms first death from novel coronavirus strain
Ng Kang-chung Published: 8:35pm, 12 Jan, 2020
Wuhan pneumonia: new strain ‘bears close similarity to Sars’ as Hong Kong health minister assures public city is prepared
Secretary for Food and Health Sophia Chan says Hong Kong has plenty of beds and protective gear, but appeals to retailers not to jack up prices of masks
Victor Ting Published: 2:21pm, 11 Jan, 2020
Jan 11, 2020 08:31 PM ENVIRONMENT
First Death From New SARS-like Virus Reported in Central China’s Wuhan
By Isabelle Li
After the following 2 articles, originally both published on January 20, 2020, 1 from SCMP and 1 from Caixin, I started to keep track of all information on this virus, which at that point was only identified as a Coronavirus infection =
Wuhan virus kills fourth patient, infects hospital staff amid fear of ‘super-spreader’
Priority now to stop emergence of ‘super-spreader’, with one carrier already infecting more than a dozen medical staff, specialist says
Authorities in Wuhan, the epicenter of the virus outbreak, report a fourth death and 15 infections among hospital staff
Gigi Choy and Alice Yan Published: 9:40pm, 20 Jan, 2020
The central Chinese city of Wuhan reported more than 130 cases of the virus over the weekend alone.
Feb 02, 2020 10:35 AM SOCIETY & CULTURE
Coronavirus Latest (Jan. 15 - Feb. 1): China Infections Reach 14,411, Apple Closes All Mainland Stores
By Flynn Murphy, Lin Jinbing, Han Wei, Dave Yin, Matthew Walsh, Denise Jia, Mo Yelin and Timmy Shen
We start a new virus daily update in February. Please follow us here.
SARS-CoV2 - BioHazard2020-1 page 1
SARS-CoV2 - BioHazard2020-2 page 2
SARS-CoV2 - BioHazard2020-3 page 3
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
COVID‑19 Information & Resources
COVID‑19 Information & Resources
COVID‑19 Information & Resources
Coronavirus disease (COVID‑19)
Also called: 2019-nCov, 2019 Novel Coronavirus
Coronavirus symptoms: What are they and how do I protect myself?
By James GallagherHealth and science correspondent 30 March 2020
https://www.bbc.com/news/health-51048366
Coronavirus symptoms: what are the common signs of Covid-19?
- As the pandemic continues its deadly spread across the globe there are some common indicators to watch out for
- Emergency warning signs include persistent chest pain or pressure, mental confusion and a bluish tinge to lips or face
Published: 4:29pm, 3 Apr, 2020
Tracking Covid-19 cases in the US
Since January, novel coronavirus has spread to nearly every state and territory
By Sergio Hernandez, Sean O’Key, Amanda Watts, Byron Manley and Henrik Pettersson, CNN
Last updated: March 30, 2020 at 8:00 p.m. ET
https://www.cnn.com/interactive/2020/health/coronavirus-us-maps-and-cases/
This map is your interactive guide to confirmed cases, recoveries and deaths from the coronavirus around the state, nation and world. It combines data from the World Health Organization, U.S. and European CDCs, and the National Health Commission of China.
https://data.courierpostonline.com/coronavirus/
https://covidtracking.com/data/
https://coronavirus.1point3acres.com/en
Coronavirus Live Updates: Despite Pushback, Trump Suggests Testing No Longer an Issue
Maryland and Virginia issued statewide stay-at-home orders, and the F.D.A. approved two malaria drugs to treat coronavirus patients. Macy’s said it would furlough most of its 125,000 workers.
RIGHT NOW
President Trump said the United States soon will be producing so many ventilators and other medical equipment that the government will be sending supplies to hard-hit Europe.
https://www.nytimes.com/2020/03/30/world/coronavirus-live-news-updates.html
Coronavirus Live Updates: U.S. Leads the World in Known Cases
https://www.nytimes.com/2020/03/26/world/coronavirus-news.html
Coronavirus in the U.S.: Latest Map and Case Count
By Mitch Smith, Karen Yourish, Sarah Almukhtar, Keith Collins, Danielle Ivory, Allison McCann, Jin Wu and Amy HarmonUpdated March 26, 2020, 5:27 P.M. E.T.
https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
https://coronavirus.jhu.edu/map.html
Mar 27, 2020 04:02 AMSOCIETY & CULTURE
Keys in Fighting Covid-19 Are Testing, Tracing, Isolation, WHO Says
By Tian Jiawei, Zeng Jia and Han Wei
Coronavirus symptoms: A list and when to seek help
By Sandee LaMotte, CNN
Updated 11:00 AM ET, Fri March 20, 2020
https://www.cnn.com/2020/03/20/health/coronavirus-symptoms-list-what-to-do-wellness/index.html
Mar 23, 2020 09:32 PM
Despite Official Figures, Wuhan Continues to Find New Asymptomatic Covid-19 Cases Daily
By Zhao Jinzhao and Dave Yin
Mar 23, 2020 09:46 PMSOCIETY & CULTURE
Coronavirus Live Updates (Monday): China’s Ambassador to U.S. Criticizes Coronavirus Conspiracy Theories
Hong Kong appeared to have the coronavirus under control, then it let its guard down
Analysis by James Griffiths, CNN
Updated 4:37 AM ET, Mon March 23, 2020
https://www.cnn.com/2020/03/23/asia/hong-kong-coronavirus-quarantine-intl-hnk/index.html
New York launches use of malaria drug to treat Covid-19
Mar. 23, 2020 1:26 PM ET|About: Tekla World Healthcare... (THW)|By: Douglas W. House, SA News Editor
https://seekingalpha.com/news/3554308-new-york-launches-use-of-malaria-drug-to-treat-covidminus-19
New York governor: "We haven't flattened the curve ... the curve is actually increasing"
Coronavirus pandemic changes life as we know it
By Jessie Yeung, Helen Regan, Adam Renton, Emma Reynolds, Mike Hayes and Meg Wagner, CNN
Updated 1:10 p.m. ET, March 24, 2020
Cuomo Says Virus Cases Increasing Rapidly Despite Lockdown
By Keshia ClukeyMarch 24, 2020, 11:16 AM EDT Updated on March 24, 2020, 11:41 AM EDT
- New York has 10 times more cases than California, Cuomo says
- Lack of ventilators seen as a huge problem once N.Y. hits apex
Mar 25, 2020 07:18 PM
High Elderly Population, Limited Testing May Underlie Italy’s High Covid-19 Death Rate: Paper
By Zeng Yukun, Ma Danmeng and Yang Ge
The George Washington University Hospital
Important Coronavirus Update
Coronavirus Disease 2019, or COVID-19
https://www.gwhospital.com/health-alert
Coronavirus: loss of smell or taste could be a symptom, growing evidence suggests
- Studies and observations in several countries indicate significant numbers of patients experience a loss of smell
- Identifying these symptoms could allow testing and isolation of people who would otherwise infect others, doctors say
Published: 4:58pm, 25 Mar, 2020
Mar 27, 2020 09:24 PMSOCIETY & CULTURE
New Study Indicates Coronavirus Spreads Easily Even When Symptoms Are Mild
By Wen Simin and Timmy Shen
Under Intense Criticism, Trump Says Government Will Buy More Ventilators
In another day of mixed messages, the president criticized G.M. and authorized the use of the Defense Production Act to force it to make ventilators after the company had already announced it was going to.
By David E. Sanger, Maggie Haberman and Annie Karni March 27, 2020
https://www.nytimes.com/2020/03/27/us/politics/coronavirus-trump-ventilators-gm-ventec.html
Coronavirus Live Updates: Pelosi Accuses Trump of ‘Deadly’ Denial and Governors Plead for Help; New York Mayor Says Medical Supplies Will Run Out in a Week
https://www.nytimes.com/2020/03/29/world/coronavirus-news.html
Coronavirus: China ramps up Covid-19 test kit exports amid global shortage, as domestic demand dries up
- More than 100 Chinese companies are selling coronavirus testing kits to Europe, but most are not licensed to sell in China
- A global shortage of kits has sparked a scramble for resources, but the specialist nature of the production process provides limitations
Finbarr Bermingham, Sidney Leng and Echo Xie in Beijing
Published: 6:00am, 30 Mar, 2020
Biotech-War$ Burn The Ships
COVID‑19 Information & Resources
COVID‑19 Information & Resources
Biotech-War$ Burn The Ships
Mar. 27, 2020 3:47 PM ET|About: Gilead Sciences, Inc. (GILD), Includes: JNJ, MRNA, RHHBY, VIR
Summary
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
The virus was the pin the popped the highly leveraged and overconfident market that many were indicating/predicting needed some adjustment. But not many were forecasting a -37% “pin” reduction vs.Jan.
an antiviral drug is a virus suppressant that blocks the chemical compounds that the virus needs for replication, its goal is to reduce the number of virus counts in the body to a manageable state.
Biotech-War$ Burn The Ships
Mar. 27, 2020 3:47 PM ET|About: Gilead Sciences, Inc. (GILD), Includes: JNJ, MRNA, RHHBY, VIR
https://seekingalpha.com/instablog/5205071-danwatson888/5426472-biotech-war-burn-ships
https://seekingbiotechalpha.com/biotechstorm
History's verdict on Trump will be devastating
By Michael D'Antonio
Updated 6:14 PM ET, Mon March 30, 2020
https://www.cnn.com/2020/03/30/opinions/history-verdict-on-trump-devastating-dantonio/index.html
Trauma physician treating coronavirus patients worries ''we are slowly descending into chaos'
By Holly Yan, Madeline Holcombe and Steve Almasy, CNN
Updated 7:52 PM ET, Mon March 30, 2020
https://www.cnn.com/2020/03/30/health/us-coronavirus-updates-monday/index.html
Nurses Die, Doctors Fall Sick and Panic Rises on Virus Front Lines
The pandemic has begun to sweep through New York City’s medical ranks, and anxiety is growing among normally dispassionate medical professionals.
- March 30, 2020, 5:00 a.m. ET
https://www.nytimes.com/2020/03/30/nyregion/ny-coronavirus-doctors-sick.html
Shielding the Fetus From the Coronavirus
New studies suggest the virus can cross the placenta, but newborns have been mildly affected if at all.
By Apoorva Mandavilli March 27, 2020
https://www.nytimes.com/2020/03/27/health/shielding-the-fetus-from-the-coronavirus.html
Some U.S. Cities Could Have Coronavirus Outbreaks Worse Than Wuhan’s
By Nate Cohn, Josh Katz, Margot Sanger-Katz and Kevin QuealyMarch 27, 2020
https://www.nytimes.com/interactive/2020/03/27/upshot/coronavirus-new-york-comparison.html
What it's like for health care workers on the front lines of the coronavirus pandemic
By Dakin Andone, CNN
Updated 8:04 PM ET, Sat March 28, 2020
https://www.cnn.com/2020/03/27/us/inside-hospitals-coronavirus-vignettes/index.html
Coronavirus death toll in the US passes 2,000 as Trump says New York quarantine 'will not be necessary'
By Dakin Andone and Christina Maxouris, CNN
Updated 9:28 PM ET, Sat March 28, 2020
https://www.cnn.com/2020/03/28/health/us-coronavirus-weekend-saturday/index.html
By Michael D. Shear, Abby Goodnough, Sheila Kaplan, Sheri Fink, Katie Thomas and Noah Weiland March 28, 2020
https://www.nytimes.com/2020/03/28/us/testing-coronavirus-pandemic.html
N.Y.C.’s 911 System Is Overwhelmed. ‘I’m Terrified,’ a Paramedic Says.
With coronavirus cases mounting, emergency workers are making life-or-death decisions about who goes to a hospital, and who is left behind.
By Ali Watkins March 28, 2020
https://www.nytimes.com/2020/03/28/nyregion/nyc-coronavirus-ems.html
Coronavirus in the U.S.: Latest Map and Case Count
By Mitch Smith, Karen Yourish, Sarah Almukhtar, Keith Collins, Danielle Ivory, Allison McCann, Jin Wu and Amy HarmonUpdated March 29, 2020, 8:02 A.M. E.T.
https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html
Let’s ‘Kick Coronavirus’s Ass’
In this nightmarish moment, we’re feeling warm and fuzzy about the cold and calculating Andrew Cuomo.
By Maureen Dowd Opinion Columnist
March 27, 2020
https://www.nytimes.com/2020/03/27/opinion/sunday/cuomo-new-york-coronavirus.html
Mar 29, 2020 12:47 PMSOCIETY & CULTURE
Zhejiang Covid-19 Infection Highlights Threat from Asymptomatic Carriers
By Zhang Erchi and Guo Yingzhe
New Chinese research may point to possible role of children in coronavirus spread
- Covid-19 symptoms tend to be milder in kids, according to studies in Zhejiang and Wuhan, with asymptomatic infections ‘not uncommon’
- But health experts say more investigation into the chain of transmission is needed
Published: 10:00am, 29 Mar, 2020
Coronavirus: China can’t suppress it, US military can’t kill it. Covid-19 is the real Godzilla
- The truth to emerge from the pandemic is that all humans share a common destiny, and we are embroiled in our biggest battle since World War II
- Only when the human race chooses to share, help, care, cooperate and support each other can we beat this enemy from nature
Published: 11:30am, 29 Mar, 2020
Decoding Covid-19
Seven human coronaviruses in seven graphics
Mar 29, 2020 06:41 PMOPINION
As U.S. Sits on Ample Ventilator Supply, China Wages Must-Win Battle to Contain Covid-19 in Hubei
By Wang Shuo
US could see millions of coronavirus cases and 100,000 or more deaths, Fauci says
By Devan Cole, CNN
Updated 1:27 PM ET, Sun March 29, 2020
https://www.cnn.com/2020/03/29/politics/coronavirus-deaths-cases-anthony-fauci-cnntv/index.html
Coronavirus: social distancing could save millions of lives, study says
- Researchers from Imperial College in London say that without steps such as social distancing Covid-19 could have killed 40 million people this year
- Study warns governments will have to make ‘challenging decisions’ but limiting social contacts could halve the death toll
Published: 7:00am, 31 Mar, 2020
Doctors on frontline of China’s battle with coronavirus tell of race to respond to onset of new disease
- One doctor in Wuhan describes the emotional toll of trying to care for Covid-19 patients and warns that the most serious cases are still struggling to make it
- Medical staff had to learn on the job when treating the previously unknown disease, which may have cost some patients their lives
Zhuang Pinghui in Beijing
Published: 7:00am, 1 Apr, 2020
Remdesivir (GS-5734)
COVID‑19 Information & Resources
the FDA has exercised “enforcement discretion” with respect to LDTs.
remdesivir
Gilead Expands Emergency Access to Experimental Coronavirus Drug
By Jason GaleMarch 28, 2020, 6:21 PM EDT Updated on March 29, 2020, 4:49 AM EDT
- Remdesivir given to over 1,000 patients for compassionate use
- Multiple clinical trials may report initial results in weeks
01-Apr-2020
GILEAD SCIENCES ANNOUNCES TWO PHASE 3 RANDOMISED STUDIES TO EVALUATE THE SAFETY AND ANTIVIRAL ACTIVITY OF REMDESIVIR (GS-5734™) IN PARTICIPANTS WITH MODERATE TO SEVERE COVID-19
- Remdesivir is an investigational agent – it is not approved anywhere globally and has not been demonstrated to be safe or effective for any use.
- The UK is one of the countries where Gilead is running clinical trials to evaluate remdesivir for the treatment of COVID-19
London, April 1st 2020 – Gilead Sciences
Gilead Sciences Statement on Request to Rescind Remdesivir Orphan Drug Designation
Gilead CEO: We're on track to have initial data in the coming weeks
Mar. 28, 2020 6:19 PM ET|About: Gilead Sciences, Inc. (GILD)|By: SA Eli Hoffmann, SA News Editor
https://seekingalpha.com/news/3556087-gilead-ceo-on-track-to-initial-data-in-coming-weeks
An Open Letter from our Chairman and CEO
Daniel O’Day - March 28, 2020
https://www.gilead.com/stories/articles/an-open-letter-from-our-chairman-and-ceo
Three coronavirus patients in Taiwan see fevers subside after taking remdesivir
Remdesivir in clinical trials to assess effectiveness in treating COVID-19
9636
By George Liao, Taiwan News, Staff Writer
2020/03/26 21:24
https://www.taiwannews.com.tw/en/news/3905171
Gilead to withdraw Orphan Drug tag for remdesivir;
Mar. 25, 2020 1:24 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Douglas W. House, SA News Editor
Covid Report: Gilead Asks FDA To Rescind Key Status For Coronavirus Drug
ALLISON GATLIN 04:15 PM ET 03/25/2020
Gilead's Remdesivir receives orphan drug status for coronavirus
Mar. 23, 2020 4:34 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Stephen Alpher, SA News Editor
https://seekingalpha.com/news/3554448-gileads-remdesivir-receives-orphan-drug-status-for-coronavirus
Gilead Sciences Update On The Company’s Ongoing Response To COVID-19
https://www.gilead.com/purpose/advancing-global-health/covid-19
https://seekingalpha.com/symbol/GILD
Gilead Mulls Hiring Remdesivir OEMs in China if Drug Passes Clinical TrialsTANG SHIHUADATE : MAR 25 2020/SOURCE : YICAI
Coronavirus Patients in Limbo as Gilead Suspends Emergency Drug Access
The company says it will switch to a broader approach for its experimental drug, remdesivir. But it was overwhelmed by demand for a potential treatment promoted by President Trump.
By Katie Thomas March 23, 2020
https://www.nytimes.com/2020/03/23/health/coronavirus-drugs-remdesivir.html
Coronavirus treatment: Palo Alto woman recovers from coronavirus after being treated with remdesivir
By David Louie
Wednesday, March 25, 2020 8:50PM
PALO ALTO, Calif. (KGO)
The race is on in the drug battle against the coronavirus
- Researchers are looking to repurpose existing pharmaceuticals to target a disease that has already killed thousands around the world
- Some have potential in helping those at greatest risk, virologist says
Published: 8:00am, 24 Mar, 2020
https://www.scmp.com/news/china/society/article/3076502/race-drug-battle-against-coronavirus
Coronavirus in NJ: Going to 'get worse before it gets better' says hospital chief
Michael L. Diamond, Asbury Park PressPublished 5:00 a.m. ET March 24, 2020 | Updated 7:44 a.m. ET March 24, 2020
Coronavirus updates: U.S. could become new coronavirus epicenter, WHO says
UPDATED ON: MARCH 24, 2020 / 2:29 PM / CBS NEWS
https://www.cbsnews.com/live-updates/coronavirus-disease-covid-19-latest-news-deaths-2020-03-24/
Coronavirus patients may be most infectious in first week of symptoms, study finds
- Researchers find viral load highest in first seven days after patients start showing signs of the disease
- Self-collected saliva samples could be safer than throat and nasal swabs taken by medical professionals, they say
Mandy Zuo in Shanghai and Holly Chik
Published: 8:30pm, 25 Mar, 2020
Opinion
Dale Fisher
Why Singapore’s coronavirus response worked – and what we can all learn
- It’s really about leadership being organised enough to get the messaging right. People will feel more comfortable and are more likely to follow the rules
- In Singapore, we want life to go on as normal. We want businesses, churches, restaurants and schools to stay open. This is what success looks like
Published: 12:42pm, 25 Mar, 2020
WHO chooses Malaysia to run trials on new drug to fight Covid-19
PUBLISHED
MAR 28, 2020, 3:00 PM SGT
PETALING JAYA (THE STAR/ASIA NEWS NETWORK)
Funeral parlour report fans fears over Wuhan death toll from coronavirus
- Magazine quotes truck driver saying he delivered thousands of funeral urns to facilities in the city last week
- Relatives of deceased only able to collect ashes in last week as centres in the city began clearing backlog
The comment came after reports that funeral homes in Wuhan have ordered thousands more urns than the official death tally of coronavirus patients in the city.
In a report on the weekend, Caixin magazine quoted a truck driver as saying he delivered about 5,000 urns on Wednesday and Thursday to the funeral parlour in Hankou district – one of eight such facilities in the city.
Published: 11:00pm, 30 Mar, 2020
the FDA has exercised “enforcement discretion” with respect to LDTs.
Coronavirus update U.S., Trump administration response under scrutiny
the FDA has exercised “enforcement discretion” with respect to LDTs.
EYE ON THE NEWS
A Self-Inflicted Crisis
Overregulation has played a dangerous role in America’s coronavirus outbreak.Roger D. KleinMarch 4, 2020 Health Care
For those without known exposures, CDC only recommends testing for severely affected patients. In theory, doctors could have tested any individuals in whom they suspected coronavirus, and Vice President Pence on March 3rd encouraged this; however, the unavailability of testing has been a major obstacle in practice. On February 4, following Health and Human Services Secretary Alex Azar’s declaration of a public-health emergency, the Food and Drug Administration issued an Emergency Use Authorization (EUA) to the CDC, allowing it to distribute test kits to designated public-health laboratories. The CDC began shipping the kits on February 5, but laboratories could not validate them because they contained a defective reagent.
Prognosis
U.S. Will Miss Coronavirus Test Rollout Goal, Senators Say
By Daniel Flatley, John Tozzi, and Shira SteinMarch 5, 2020, 9:48 AM EST Updated on March 5, 2020, 12:10 PM EST
- GOP senators says kits to be in mail by end of this week
- Distribution, training ‘going to take time,’ Lankford says
Mar 07, 2020 08:25 AMSOCIETY & CULTURE
Covid-19 Relapse Mystery May Be Linked to Controversial Treatment, Researchers Say
By Zhang Yang, Huang Shulun and Denise Jia
Facts about novel coronavirus and how to prevent COVID-19
March 6, 2020 at 7:19 am Updated March 7, 2020 at 11:08 am
By
Seattle Times graphics editor
Prognosis
Virus Testing Blitz Appears to Keep Korea Death Rate Low
By Heejin Kim, Sohee Kim, and Claire CheMarch 4, 2020, 4:00 PM EST Updated on March 5, 2020, 1:18 AM EST
- Country is testing at fastest global pace as cases top 5,000
- Faulty, limited testing in Japan, U.S., could worsen outbreak
How South Korea Scaled Coronavirus Testing While the U.S. Fell Dangerously Behind
By learning from a MERS outbreak in 2015, South Korea was prepared and acted swiftly to ramp up testing when the new coronavirus appeared there. Meanwhile, the U.S., plagued by delay and dysfunction, wasted its advantage.
by Stephen Engelberg, Lisa Song and Lydia DePillis
March 15, 11:10 a.m. EDT
WATCH: FDA Seeks To Expand Treatment Options For Coronavirus
March 19, 20209:26 AM ET
Coronavirus: Grim toll as Italy’s Covid-19 deaths surpass those of China
- Italian authorities announce 427 new deaths, pushing the total to 3,405 and exceeding mainland China’s 3,242
- In Madrid, death rate is described by health authorities as ‘one case every 16 minutes’
Published: 12:08am, 20 Mar, 2020
What Two Months of Reporting Has Taught Caixin About the Coronavirus
Coronavirus update U.S., Trump administration response under scrutiny
Coronavirus update U.S., Trump administration response under scrutiny
Mar 16, 2020 09:15 PMSOCIETY & CULTURE
Reporter’s Notebook: What Two Months of Reporting Has Taught Caixin About the Coronavirus
By Han Wei
How China’s military took a frontline role in the coronavirus crisis
- Chinese President Xi Jinping, who gave army medical teams the heaviest responsibilities, says virus is now ‘basically curbed’ thanks to their efforts
- PLA’s Academy of Military Medical Sciences personnel have decades of experience including tackling Sars, Ebola, and the earthquake that shattered Sichuan in 2008
Published: 6:00am, 17 Mar, 2020
Coronavirus: China’s economy suffers dramatic collapse in January, February in warning to rest of world
- Combined data for January and February showed that industrial production, retail sales and asset investment all declined far more than analysts expected
- Lockdowns to control the coronavirus proved to be a constraint to economic growth, but with China now in recovery, data suggests what rest of the world could expect
Finbarr Bermingham and Orange Wang
Published: 10:00am, 16 Mar, 2020
Mar 16, 2020 08:58 PMBUSINESS & TECH
Restaurants in China Are Reopening, But Finding It Hard to Recover Business
By Shen Xinyue and Isabelle Li
COVID-19: Containing and conquering a global health threat
The Fatal Impact of Coronavirus Lockdown
One chart shows how the coronavirus is more deadly than the flu even in South Korea, where the COVID-19 death rate is low
Andy Kiersz Mar 12, 2020, 5:18 PM
https://www.businessinsider.com/coronavirus-death-rate-south-korea-compared-to-flu-2020-3
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
https://www.journalofhospitalinfection.com/article/S0195-6701(20)30046-3/pdf
The incompetence pandemic
- The first victim of the coronavirus? Leadership
Published: 12:49pm, 16 Mar, 2020
https://www.scmp.com/news/world/united-states-canada/article/3075336/incompetence-pandemic
This story is published in a content partnership with POLITICO. It was originally reported by Matthew Karnitschnig on
on March 16, 2020.
The incompetence pandemic
The first victim of the coronavirus? Leadership.
https://www.politico.com/news/2020/03/16/coronavirus-pandemic-leadership-131540
Coronavirus: US officials overruled expert advice on listing places visited by Patient 1
- Emails reveal that Washington state health officials ignored an earlier plan by a senior epidemiologist to name locations
- Hong Kong, South Korea and Singapore have been credited with slowing the outbreak by disclosing details about the movements of infected patients
Published: 8:00pm, 23 Mar, 2020
Coronavirus update U.S., Trump administration response under scrutiny
Coronavirus update U.S., Trump administration response under scrutiny
Coronavirus update U.S., Trump administration response under scrutiny
Coronavirus update: 82,550 cases, 2,810 deaths, 1 possible case of spread in the U.S., Trump administration response under scrutiny
142Published: Feb. 27, 2020 at 3:26 p.m. ETBy
A woman in Northern California who tested positive for COVID-19 had not traveled to an affected country or likely been in contact with another confirmed case
Mar 06, 2020 06:39 AMSOCIETY & CULTURE
Coronavirus Live Updates (Thursday): As Domestic Outbreak Ebbs, China Faces Waves of Cases Imported From Iran, Italy
10 measures to help control epidemic, restart work
chinadaily.com.cn | Updated: 2020-03-05 20:37
http://global.chinadaily.com.cn/a/202003/05/WS5e60f294a31012821727caf7.html
Coronavirus: global infections could increase tenfold every 19 days, Chinese study says
- Nation’s leading geneticist Jin Li calls on the world to ‘take strong actions on public health, using experiences learned from China and Singapore’
- Chilling forecast based on simple linear model, though research has yet to be peer-reviewed
Stephen Chen in Beijing
Published: 6:11pm, 7 Mar, 2020
Coronavirus
LAST UPDATED: MAR 7, 9
Source: China's NHC, state media, other authorities
https://multimedia.scmp.com/widgets/china/wuhanvirus/
How It All Started: China’s Early Coronavirus Missteps
China’s errors, dating back to the very first patients, were compounded by political leaders who dragged their feet to inform the public of the risks and to take decisive control measures
By Jeremy Page, Wenxin Fan and Natasha KhanMarch 6, 2020 10:36 am ET
Mar 16, 2020 01:14 PM
Coronavirus Live Updates (Monday): Fed Cuts Rate to Near Zero; Deaths Outside China Hit More Than 3,200
China CDC Weekly > 2020, 2(4): 61-62
Notes from the Field: A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020
http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c
Younger adults less immune to Covid-19 health risks than thought, US agency’s study suggests
- A top American health official and US President Donald Trump urged the country’s millennials to heed social distancing guidelines
- Data from Centres for Disease Control and Prevention showed that a fifth of 705 people aged 20-44 were hospitalised, with 2-4 per cent requiring intensive care
Published: 6:01am, 19 Mar, 2020
Mar 20, 2020 05:00 AMSOCIETY & CULTURE
Coronavirus Live Updates (Thursday): Italy’s Death Toll Surpasses China’s; India Bars Inbound Flights
When You Die of the Coronavirus, You Die Alone
Containing a pandemic means keeping visitors out of the I.C.U. My patients will suffer in solitary confinement.
By Daniela J. Lamas
Dr. Lamas is critical care doctor.
- March 24, 2020, 5:00 a.m. ET
https://www.nytimes.com/2020/03/24/opinion/coronavirus-hospital-visits.html
number of people tested in US on 3/10/2020 for coronavirus = 8
Coronavirus: some recovered patients - reduced lung function & are gasping for air walking, HK docs
Coronavirus: China’s ravaged manufacturing heartlands force international firms to speed up exit
Testing in the U.S.
Updated March 11, 2020
This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.
CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak first started in Wuhan, China, but cases have been identified in a growing number of other locations internationally, including the United States.
number of people tested in US on 3/10/2020 for coronavirus = 8
INFECTIOUS DISEASES CORONAVIRUS (COVID-19)PRINT
A Timeline of Coronavirus (COVID-19)
How It Started and Where It's Spreading
By Team Verywell Fact checked by James Lacy Updated on March 12, 2020
https://www.verywellhealth.com/coronavirus-covid-19-timeline-4798671
QIAGEN Gains BARDA Funding for Approval Process of QIAstat-Dx Test Kit for SARS-CoV-2 Coronavirus
Fri March 13, 2020 9:01 AM|Business Wire|About: QGEN
- First syndromic testing solution to get U.S. agency’s development support in novel coronavirus response
- QIAstat-Dx Respiratory SARS-CoV-2 Panel test kit will rapidly differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes
- Further expanding QIAGEN’s global mobilization to scale up testing supplies for the COVID-19 response
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA)
https://seekingalpha.com/symbol/QGEN
Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
- First commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs
- Testing on widely available, high-volume cobas 6800/8800 will significantly increase available testing capacity
- Roche expedites test development to support urgent need for patient testing during pandemic outbreak to avoid a further spread of the virus at an early stage of infection
Basel, 13 March 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY)
https://www.roche.com/media/releases/med-cor-2020-03-13.htm
https://seekingalpha.com/symbol/RHHBY
FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19
Fri March 13, 2020 10:09 PM|PR Newswire|About: TMO
WALTHAM, Mass., March 13, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO)
TaqPath COVID-19 Multiplex Diagnostic Solution
Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization
- Broad network of labs will use automated cobas SARS-CoV-2 Test to process high volume of patient samples sent from across US
- First available commercial test kit for novel coronavirus will enable labs to expand and expedite testing to meet urgent medical needs
cobas® SARS-CoV-2 Test
https://diagnostics.roche.com/global/en/products/params/cobas-sars-cov-2-test.html
Coronavirus: China’s ravaged manufacturing heartlands force international firms to speed up exit
Coronavirus: some recovered patients - reduced lung function & are gasping for air walking, HK docs
Coronavirus: China’s ravaged manufacturing heartlands force international firms to speed up exit
Coronavirus: China’s ravaged manufacturing heartlands force international firms to speed up exit strategies
- Some multinationals are increasingly fleeing China, having seen the coronavirus outbreak as validation of exit strategies made during the US trade war
- While some bemoan the lack of alternatives, others will stay for the domestic market as the supply chain debate rages on
Published: 12:00pm, 5 Mar, 2020
Opinion
Minxin Pei
How China’s coronavirus crisis exposes the Achilles’ heel of Communist Party power
- The party’s initial mishandling of the outbreak has eroded support among China’s urban middle class
- The brief but intense eruption of public criticism is a taste of how such missteps can threaten the social contract on which the party’s legitimacy is built
Published: 12:30am, 6 Mar, 2020
Coronavirus: US Secretary of State Mike Pompeo switches disease name to ‘Wuhan virus’ as it spreads in the US
- Top US diplomat ignores pleas from Beijing and world health officials over the use of names for the Covid-19 disease that incite racial discrimination
- New nomenclature comes with President Donald Trump’s administration under fire over its response to community transmission of the virus in the US
Published: 4:58am, 7 Mar, 2020
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
Addressing the potential impact of novel coronavirus disease (COVID-19) on medicines supply in the EU
ShareNews 10/03/2020
Prognosis
Coronavirus Outbreak Likely Began With Bats, an Omen for Next Epidemic
Scientists say future pandemics are inevitable as cities and villages encroach on wild habitats